A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)
Trial details
- Registry ID
- NCT06616974
- Drugs studied
- TX000045- Dose A, TX000045- Dose B
TrialRedline tracks 1 clinical trial sponsored by Tectonic Therapeutic: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974 | TX000045- Dose A, TX000045- Dose B | Active not recruiting | 2026-11-24Estimated |
Names as written in the registry records.
NCT06616974 · Tectonic Therapeutic
Before: 180 participants (planned). After: 191 participants (planned).
Before: 9 Oct 2026. After: 24 Nov 2026.
Before: Recruiting. After: Active not recruiting.